E
VIVE

Ergoteles’s VIVEVE MED INC VIVE Stock Holding History

Ergoteles’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,600
Closed -$18K – 2127
2022
Q1 		$18K Buy
+16,600
New +$16.6K ﹤0.01% 1159

Other funds holding VIVE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Ergoteles's VIVE Position: Q2 2022 in Review

Ergoteles sold out of VIVEVE MED INC (VIVE) in Q2 2022, closing a stake of 16,600 shares — an estimated $18K sold.

Ergoteles first reported a position in VIVE in Q1 2022 and held it in 1 quarter. The position peaked at $18K in Q1 2022. 20 funds tracked by Wall St. Rank hold VIVE as of Q2 2022.

  • Ergoteles reported no remaining VIVEVE MED INC position as of Q2 2022 after selling out during the quarter.
  • Ergoteles sold 16,600 VIVEVE MED INC shares in Q2 2022, an estimated $18K.
  • Ergoteles first reported a position in VIVEVE MED INC in Q1 2022 and held it in 1 quarter.
  • Ergoteles's VIVEVE MED INC position peaked at $18K in Q1 2022.
  • 20 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q2 2022.

Based on Ergoteles's 13F filing for Q2 2022, filed 12 Aug 2022.